Global Viral Gene Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Description

According to our (Global Info Research) latest study, the global Viral Gene Therapy market size was valued at USD 7305.5 million in 2022 and is forecast to a readjusted size of USD 21600 million by 2029 with a CAGR of 16.7% during review period.

Gene therapy is the treatment of a genetic disease by the introduction of specific cell function-altering genetic material into a patient. The key step in gene therapy is efficient gene delivery to the target tissue/cells, which is carried out by gene delivery vehicles called vectors.

A robust gene therapy pipeline is expected to boost the gene therapy market growth in the forecast period.

The Global Info Research report includes an overview of the development of the Viral Gene Therapy industry chain, the market status of Metabolic Diseases (Integrating Viral Vectors, Non-Integrating Viral Vectors), Cardiovascular Diseases (Integrating Viral Vectors, Non-Integrating Viral Vectors), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Viral Gene Therapy.

Regionally, the report analyzes the Viral Gene Therapy markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Viral Gene Therapy market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Viral Gene Therapy market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Viral Gene Therapy industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Integrating Viral Vectors, Non-Integrating Viral Vectors).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Viral Gene Therapy market.

Regional Analysis: The report involves examining the Viral Gene Therapy market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Viral Gene Therapy market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Viral Gene Therapy:
Company Analysis: Report covers individual Viral Gene Therapy players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Viral Gene Therapy This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Metabolic Diseases, Cardiovascular Diseases).

Technology Analysis: Report covers specific technologies relevant to Viral Gene Therapy. It assesses the current state, advancements, and potential future developments in Viral Gene Therapy areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Viral Gene Therapy market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Viral Gene Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
    Integrating Viral Vectors
    Non-Integrating Viral Vectors

Market segment by Application
    Metabolic Diseases
    Cardiovascular Diseases
    Muscular Diseases
    Hematologic Diseases
    Ophthalmologic Diseases
    Infectious Diseases
    Others

Market segment by players, this report covers
    Lonza
    Biogen
    Catalent
    Gilead Sciences
    Sarepta Therapeutics
    Novartis
    Amgen
    Ionis Pharmaceuticals
    Spark Therapeutics
    Shanghai Sunway Biotech
    SIBIONO
    AnGes
    Orchard Therapeutics

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Viral Gene Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Viral Gene Therapy, with revenue, gross margin and global market share of Viral Gene Therapy from 2018 to 2023.
Chapter 3, the Viral Gene Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Viral Gene Therapy market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Viral Gene Therapy.
Chapter 13, to describe Viral Gene Therapy research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Viral Gene Therapy
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Viral Gene Therapy by Type
        1.3.1 Overview: Global Viral Gene Therapy Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Viral Gene Therapy Consumption Value Market Share by Type in 2022
        1.3.3 Integrating Viral Vectors
        1.3.4 Non-Integrating Viral Vectors
    1.4 Global Viral Gene Therapy Market by Application
        1.4.1 Overview: Global Viral Gene Therapy Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Metabolic Diseases
        1.4.3 Cardiovascular Diseases
        1.4.4 Muscular Diseases
        1.4.5 Hematologic Diseases
        1.4.6 Ophthalmologic Diseases
        1.4.7 Infectious Diseases
        1.4.8 Others
    1.5 Global Viral Gene Therapy Market Size & Forecast
    1.6 Global Viral Gene Therapy Market Size and Forecast by Region
        1.6.1 Global Viral Gene Therapy Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Viral Gene Therapy Market Size by Region, (2018-2029)
        1.6.3 North America Viral Gene Therapy Market Size and Prospect (2018-2029)
        1.6.4 Europe Viral Gene Therapy Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Viral Gene Therapy Market Size and Prospect (2018-2029)
        1.6.6 South America Viral Gene Therapy Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Viral Gene Therapy Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 Lonza
        2.1.1 Lonza Details
        2.1.2 Lonza Major Business
        2.1.3 Lonza Viral Gene Therapy Product and Solutions
        2.1.4 Lonza Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Lonza Recent Developments and Future Plans
    2.2 Biogen
        2.2.1 Biogen Details
        2.2.2 Biogen Major Business
        2.2.3 Biogen Viral Gene Therapy Product and Solutions
        2.2.4 Biogen Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Biogen Recent Developments and Future Plans
    2.3 Catalent
        2.3.1 Catalent Details
        2.3.2 Catalent Major Business
        2.3.3 Catalent Viral Gene Therapy Product and Solutions
        2.3.4 Catalent Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Catalent Recent Developments and Future Plans
    2.4 Gilead Sciences
        2.4.1 Gilead Sciences Details
        2.4.2 Gilead Sciences Major Business
        2.4.3 Gilead Sciences Viral Gene Therapy Product and Solutions
        2.4.4 Gilead Sciences Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Gilead Sciences Recent Developments and Future Plans
    2.5 Sarepta Therapeutics
        2.5.1 Sarepta Therapeutics Details
        2.5.2 Sarepta Therapeutics Major Business
        2.5.3 Sarepta Therapeutics Viral Gene Therapy Product and Solutions
        2.5.4 Sarepta Therapeutics Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Sarepta Therapeutics Recent Developments and Future Plans
    2.6 Novartis
        2.6.1 Novartis Details
        2.6.2 Novartis Major Business
        2.6.3 Novartis Viral Gene Therapy Product and Solutions
        2.6.4 Novartis Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Novartis Recent Developments and Future Plans
    2.7 Amgen
        2.7.1 Amgen Details
        2.7.2 Amgen Major Business
        2.7.3 Amgen Viral Gene Therapy Product and Solutions
        2.7.4 Amgen Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Amgen Recent Developments and Future Plans
    2.8 Ionis Pharmaceuticals
        2.8.1 Ionis Pharmaceuticals Details
        2.8.2 Ionis Pharmaceuticals Major Business
        2.8.3 Ionis Pharmaceuticals Viral Gene Therapy Product and Solutions
        2.8.4 Ionis Pharmaceuticals Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Ionis Pharmaceuticals Recent Developments and Future Plans
    2.9 Spark Therapeutics
        2.9.1 Spark Therapeutics Details
        2.9.2 Spark Therapeutics Major Business
        2.9.3 Spark Therapeutics Viral Gene Therapy Product and Solutions
        2.9.4 Spark Therapeutics Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Spark Therapeutics Recent Developments and Future Plans
    2.10 Shanghai Sunway Biotech
        2.10.1 Shanghai Sunway Biotech Details
        2.10.2 Shanghai Sunway Biotech Major Business
        2.10.3 Shanghai Sunway Biotech Viral Gene Therapy Product and Solutions
        2.10.4 Shanghai Sunway Biotech Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Shanghai Sunway Biotech Recent Developments and Future Plans
    2.11 SIBIONO
        2.11.1 SIBIONO Details
        2.11.2 SIBIONO Major Business
        2.11.3 SIBIONO Viral Gene Therapy Product and Solutions
        2.11.4 SIBIONO Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 SIBIONO Recent Developments and Future Plans
    2.12 AnGes
        2.12.1 AnGes Details
        2.12.2 AnGes Major Business
        2.12.3 AnGes Viral Gene Therapy Product and Solutions
        2.12.4 AnGes Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 AnGes Recent Developments and Future Plans
    2.13 Orchard Therapeutics
        2.13.1 Orchard Therapeutics Details
        2.13.2 Orchard Therapeutics Major Business
        2.13.3 Orchard Therapeutics Viral Gene Therapy Product and Solutions
        2.13.4 Orchard Therapeutics Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 Orchard Therapeutics Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Viral Gene Therapy Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Viral Gene Therapy by Company Revenue
        3.2.2 Top 3 Viral Gene Therapy Players Market Share in 2022
        3.2.3 Top 6 Viral Gene Therapy Players Market Share in 2022
    3.3 Viral Gene Therapy Market: Overall Company Footprint Analysis
        3.3.1 Viral Gene Therapy Market: Region Footprint
        3.3.2 Viral Gene Therapy Market: Company Product Type Footprint
        3.3.3 Viral Gene Therapy Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Viral Gene Therapy Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Viral Gene Therapy Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global Viral Gene Therapy Consumption Value Market Share by Application (2018-2023)
    5.2 Global Viral Gene Therapy Market Forecast by Application (2024-2029)

6 North America
    6.1 North America Viral Gene Therapy Consumption Value by Type (2018-2029)
    6.2 North America Viral Gene Therapy Consumption Value by Application (2018-2029)
    6.3 North America Viral Gene Therapy Market Size by Country
        6.3.1 North America Viral Gene Therapy Consumption Value by Country (2018-2029)
        6.3.2 United States Viral Gene Therapy Market Size and Forecast (2018-2029)
        6.3.3 Canada Viral Gene Therapy Market Size and Forecast (2018-2029)
        6.3.4 Mexico Viral Gene Therapy Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe Viral Gene Therapy Consumption Value by Type (2018-2029)
    7.2 Europe Viral Gene Therapy Consumption Value by Application (2018-2029)
    7.3 Europe Viral Gene Therapy Market Size by Country
        7.3.1 Europe Viral Gene Therapy Consumption Value by Country (2018-2029)
        7.3.2 Germany Viral Gene Therapy Market Size and Forecast (2018-2029)
        7.3.3 France Viral Gene Therapy Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Viral Gene Therapy Market Size and Forecast (2018-2029)
        7.3.5 Russia Viral Gene Therapy Market Size and Forecast (2018-2029)
        7.3.6 Italy Viral Gene Therapy Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific Viral Gene Therapy Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Viral Gene Therapy Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Viral Gene Therapy Market Size by Region
        8.3.1 Asia-Pacific Viral Gene Therapy Consumption Value by Region (2018-2029)
        8.3.2 China Viral Gene Therapy Market Size and Forecast (2018-2029)
        8.3.3 Japan Viral Gene Therapy Market Size and Forecast (2018-2029)
        8.3.4 South Korea Viral Gene Therapy Market Size and Forecast (2018-2029)
        8.3.5 India Viral Gene Therapy Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Viral Gene Therapy Market Size and Forecast (2018-2029)
        8.3.7 Australia Viral Gene Therapy Market Size and Forecast (2018-2029)

9 South America
    9.1 South America Viral Gene Therapy Consumption Value by Type (2018-2029)
    9.2 South America Viral Gene Therapy Consumption Value by Application (2018-2029)
    9.3 South America Viral Gene Therapy Market Size by Country
        9.3.1 South America Viral Gene Therapy Consumption Value by Country (2018-2029)
        9.3.2 Brazil Viral Gene Therapy Market Size and Forecast (2018-2029)
        9.3.3 Argentina Viral Gene Therapy Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa Viral Gene Therapy Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Viral Gene Therapy Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Viral Gene Therapy Market Size by Country
        10.3.1 Middle East & Africa Viral Gene Therapy Consumption Value by Country (2018-2029)
        10.3.2 Turkey Viral Gene Therapy Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Viral Gene Therapy Market Size and Forecast (2018-2029)
        10.3.4 UAE Viral Gene Therapy Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 Viral Gene Therapy Market Drivers
    11.2 Viral Gene Therapy Market Restraints
    11.3 Viral Gene Therapy Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Viral Gene Therapy Industry Chain
    12.2 Viral Gene Therapy Upstream Analysis
    12.3 Viral Gene Therapy Midstream Analysis
    12.4 Viral Gene Therapy Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Viral Gene Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Viral Gene Therapy Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global Viral Gene Therapy Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global Viral Gene Therapy Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. Lonza Company Information, Head Office, and Major Competitors
    Table 6. Lonza Major Business
    Table 7. Lonza Viral Gene Therapy Product and Solutions
    Table 8. Lonza Viral Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. Lonza Recent Developments and Future Plans
    Table 10. Biogen Company Information, Head Office, and Major Competitors
    Table 11. Biogen Major Business
    Table 12. Biogen Viral Gene Therapy Product and Solutions
    Table 13. Biogen Viral Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. Biogen Recent Developments and Future Plans
    Table 15. Catalent Company Information, Head Office, and Major Competitors
    Table 16. Catalent Major Business
    Table 17. Catalent Viral Gene Therapy Product and Solutions
    Table 18. Catalent Viral Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. Catalent Recent Developments and Future Plans
    Table 20. Gilead Sciences Company Information, Head Office, and Major Competitors
    Table 21. Gilead Sciences Major Business
    Table 22. Gilead Sciences Viral Gene Therapy Product and Solutions
    Table 23. Gilead Sciences Viral Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. Gilead Sciences Recent Developments and Future Plans
    Table 25. Sarepta Therapeutics Company Information, Head Office, and Major Competitors
    Table 26. Sarepta Therapeutics Major Business
    Table 27. Sarepta Therapeutics Viral Gene Therapy Product and Solutions
    Table 28. Sarepta Therapeutics Viral Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. Sarepta Therapeutics Recent Developments and Future Plans
    Table 30. Novartis Company Information, Head Office, and Major Competitors
    Table 31. Novartis Major Business
    Table 32. Novartis Viral Gene Therapy Product and Solutions
    Table 33. Novartis Viral Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. Novartis Recent Developments and Future Plans
    Table 35. Amgen Company Information, Head Office, and Major Competitors
    Table 36. Amgen Major Business
    Table 37. Amgen Viral Gene Therapy Product and Solutions
    Table 38. Amgen Viral Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 39. Amgen Recent Developments and Future Plans
    Table 40. Ionis Pharmaceuticals Company Information, Head Office, and Major Competitors
    Table 41. Ionis Pharmaceuticals Major Business
    Table 42. Ionis Pharmaceuticals Viral Gene Therapy Product and Solutions
    Table 43. Ionis Pharmaceuticals Viral Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 44. Ionis Pharmaceuticals Recent Developments and Future Plans
    Table 45. Spark Therapeutics Company Information, Head Office, and Major Competitors
    Table 46. Spark Therapeutics Major Business
    Table 47. Spark Therapeutics Viral Gene Therapy Product and Solutions
    Table 48. Spark Therapeutics Viral Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 49. Spark Therapeutics Recent Developments and Future Plans
    Table 50. Shanghai Sunway Biotech Company Information, Head Office, and Major Competitors
    Table 51. Shanghai Sunway Biotech Major Business
    Table 52. Shanghai Sunway Biotech Viral Gene Therapy Product and Solutions
    Table 53. Shanghai Sunway Biotech Viral Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 54. Shanghai Sunway Biotech Recent Developments and Future Plans
    Table 55. SIBIONO Company Information, Head Office, and Major Competitors
    Table 56. SIBIONO Major Business
    Table 57. SIBIONO Viral Gene Therapy Product and Solutions
    Table 58. SIBIONO Viral Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 59. SIBIONO Recent Developments and Future Plans
    Table 60. AnGes Company Information, Head Office, and Major Competitors
    Table 61. AnGes Major Business
    Table 62. AnGes Viral Gene Therapy Product and Solutions
    Table 63. AnGes Viral Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 64. AnGes Recent Developments and Future Plans
    Table 65. Orchard Therapeutics Company Information, Head Office, and Major Competitors
    Table 66. Orchard Therapeutics Major Business
    Table 67. Orchard Therapeutics Viral Gene Therapy Product and Solutions
    Table 68. Orchard Therapeutics Viral Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 69. Orchard Therapeutics Recent Developments and Future Plans
    Table 70. Global Viral Gene Therapy Revenue (USD Million) by Players (2018-2023)
    Table 71. Global Viral Gene Therapy Revenue Share by Players (2018-2023)
    Table 72. Breakdown of Viral Gene Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 73. Market Position of Players in Viral Gene Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 74. Head Office of Key Viral Gene Therapy Players
    Table 75. Viral Gene Therapy Market: Company Product Type Footprint
    Table 76. Viral Gene Therapy Market: Company Product Application Footprint
    Table 77. Viral Gene Therapy New Market Entrants and Barriers to Market Entry
    Table 78. Viral Gene Therapy Mergers, Acquisition, Agreements, and Collaborations
    Table 79. Global Viral Gene Therapy Consumption Value (USD Million) by Type (2018-2023)
    Table 80. Global Viral Gene Therapy Consumption Value Share by Type (2018-2023)
    Table 81. Global Viral Gene Therapy Consumption Value Forecast by Type (2024-2029)
    Table 82. Global Viral Gene Therapy Consumption Value by Application (2018-2023)
    Table 83. Global Viral Gene Therapy Consumption Value Forecast by Application (2024-2029)
    Table 84. North America Viral Gene Therapy Consumption Value by Type (2018-2023) & (USD Million)
    Table 85. North America Viral Gene Therapy Consumption Value by Type (2024-2029) & (USD Million)
    Table 86. North America Viral Gene Therapy Consumption Value by Application (2018-2023) & (USD Million)
    Table 87. North America Viral Gene Therapy Consumption Value by Application (2024-2029) & (USD Million)
    Table 88. North America Viral Gene Therapy Consumption Value by Country (2018-2023) & (USD Million)
    Table 89. North America Viral Gene Therapy Consumption Value by Country (2024-2029) & (USD Million)
    Table 90. Europe Viral Gene Therapy Consumption Value by Type (2018-2023) & (USD Million)
    Table 91. Europe Viral Gene Therapy Consumption Value by Type (2024-2029) & (USD Million)
    Table 92. Europe Viral Gene Therapy Consumption Value by Application (2018-2023) & (USD Million)
    Table 93. Europe Viral Gene Therapy Consumption Value by Application (2024-2029) & (USD Million)
    Table 94. Europe Viral Gene Therapy Consumption Value by Country (2018-2023) & (USD Million)
    Table 95. Europe Viral Gene Therapy Consumption Value by Country (2024-2029) & (USD Million)
    Table 96. Asia-Pacific Viral Gene Therapy Consumption Value by Type (2018-2023) & (USD Million)
    Table 97. Asia-Pacific Viral Gene Therapy Consumption Value by Type (2024-2029) & (USD Million)
    Table 98. Asia-Pacific Viral Gene Therapy Consumption Value by Application (2018-2023) & (USD Million)
    Table 99. Asia-Pacific Viral Gene Therapy Consumption Value by Application (2024-2029) & (USD Million)
    Table 100. Asia-Pacific Viral Gene Therapy Consumption Value by Region (2018-2023) & (USD Million)
    Table 101. Asia-Pacific Viral Gene Therapy Consumption Value by Region (2024-2029) & (USD Million)
    Table 102. South America Viral Gene Therapy Consumption Value by Type (2018-2023) & (USD Million)
    Table 103. South America Viral Gene Therapy Consumption Value by Type (2024-2029) & (USD Million)
    Table 104. South America Viral Gene Therapy Consumption Value by Application (2018-2023) & (USD Million)
    Table 105. South America Viral Gene Therapy Consumption Value by Application (2024-2029) & (USD Million)
    Table 106. South America Viral Gene Therapy Consumption Value by Country (2018-2023) & (USD Million)
    Table 107. South America Viral Gene Therapy Consumption Value by Country (2024-2029) & (USD Million)
    Table 108. Middle East & Africa Viral Gene Therapy Consumption Value by Type (2018-2023) & (USD Million)
    Table 109. Middle East & Africa Viral Gene Therapy Consumption Value by Type (2024-2029) & (USD Million)
    Table 110. Middle East & Africa Viral Gene Therapy Consumption Value by Application (2018-2023) & (USD Million)
    Table 111. Middle East & Africa Viral Gene Therapy Consumption Value by Application (2024-2029) & (USD Million)
    Table 112. Middle East & Africa Viral Gene Therapy Consumption Value by Country (2018-2023) & (USD Million)
    Table 113. Middle East & Africa Viral Gene Therapy Consumption Value by Country (2024-2029) & (USD Million)
    Table 114. Viral Gene Therapy Raw Material
    Table 115. Key Suppliers of Viral Gene Therapy Raw Materials
List of Figures
    Figure 1. Viral Gene Therapy Picture
    Figure 2. Global Viral Gene Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Viral Gene Therapy Consumption Value Market Share by Type in 2022
    Figure 4. Integrating Viral Vectors
    Figure 5. Non-Integrating Viral Vectors
    Figure 6. Global Viral Gene Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 7. Viral Gene Therapy Consumption Value Market Share by Application in 2022
    Figure 8. Metabolic Diseases Picture
    Figure 9. Cardiovascular Diseases Picture
    Figure 10. Muscular Diseases Picture
    Figure 11. Hematologic Diseases Picture
    Figure 12. Ophthalmologic Diseases Picture
    Figure 13. Infectious Diseases Picture
    Figure 14. Others Picture
    Figure 15. Global Viral Gene Therapy Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 16. Global Viral Gene Therapy Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 17. Global Market Viral Gene Therapy Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 18. Global Viral Gene Therapy Consumption Value Market Share by Region (2018-2029)
    Figure 19. Global Viral Gene Therapy Consumption Value Market Share by Region in 2022
    Figure 20. North America Viral Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 21. Europe Viral Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 22. Asia-Pacific Viral Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 23. South America Viral Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 24. Middle East and Africa Viral Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 25. Global Viral Gene Therapy Revenue Share by Players in 2022
    Figure 26. Viral Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 27. Global Top 3 Players Viral Gene Therapy Market Share in 2022
    Figure 28. Global Top 6 Players Viral Gene Therapy Market Share in 2022
    Figure 29. Global Viral Gene Therapy Consumption Value Share by Type (2018-2023)
    Figure 30. Global Viral Gene Therapy Market Share Forecast by Type (2024-2029)
    Figure 31. Global Viral Gene Therapy Consumption Value Share by Application (2018-2023)
    Figure 32. Global Viral Gene Therapy Market Share Forecast by Application (2024-2029)
    Figure 33. North America Viral Gene Therapy Consumption Value Market Share by Type (2018-2029)
    Figure 34. North America Viral Gene Therapy Consumption Value Market Share by Application (2018-2029)
    Figure 35. North America Viral Gene Therapy Consumption Value Market Share by Country (2018-2029)
    Figure 36. United States Viral Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 37. Canada Viral Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 38. Mexico Viral Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 39. Europe Viral Gene Therapy Consumption Value Market Share by Type (2018-2029)
    Figure 40. Europe Viral Gene Therapy Consumption Value Market Share by Application (2018-2029)
    Figure 41. Europe Viral Gene Therapy Consumption Value Market Share by Country (2018-2029)
    Figure 42. Germany Viral Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 43. France Viral Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 44. United Kingdom Viral Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 45. Russia Viral Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 46. Italy Viral Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 47. Asia-Pacific Viral Gene Therapy Consumption Value Market Share by Type (2018-2029)
    Figure 48. Asia-Pacific Viral Gene Therapy Consumption Value Market Share by Application (2018-2029)
    Figure 49. Asia-Pacific Viral Gene Therapy Consumption Value Market Share by Region (2018-2029)
    Figure 50. China Viral Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 51. Japan Viral Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 52. South Korea Viral Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 53. India Viral Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 54. Southeast Asia Viral Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 55. Australia Viral Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 56. South America Viral Gene Therapy Consumption Value Market Share by Type (2018-2029)
    Figure 57. South America Viral Gene Therapy Consumption Value Market Share by Application (2018-2029)
    Figure 58. South America Viral Gene Therapy Consumption Value Market Share by Country (2018-2029)
    Figure 59. Brazil Viral Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 60. Argentina Viral Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 61. Middle East and Africa Viral Gene Therapy Consumption Value Market Share by Type (2018-2029)
    Figure 62. Middle East and Africa Viral Gene Therapy Consumption Value Market Share by Application (2018-2029)
    Figure 63. Middle East and Africa Viral Gene Therapy Consumption Value Market Share by Country (2018-2029)
    Figure 64. Turkey Viral Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 65. Saudi Arabia Viral Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 66. UAE Viral Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 67. Viral Gene Therapy Market Drivers
    Figure 68. Viral Gene Therapy Market Restraints
    Figure 69. Viral Gene Therapy Market Trends
    Figure 70. Porters Five Forces Analysis
    Figure 71. Manufacturing Cost Structure Analysis of Viral Gene Therapy in 2022
    Figure 72. Manufacturing Process Analysis of Viral Gene Therapy
    Figure 73. Viral Gene Therapy Industrial Chain
    Figure 74. Methodology
    Figure 75. Research Process and Data Source

Companies Mentioned

Lonza
Biogen
Catalent
Gilead Sciences
Sarepta Therapeutics
Novartis
Amgen
Ionis Pharmaceuticals
Spark Therapeutics
Shanghai Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics